Greenbrook

About:

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

Website: https://www.greenbrooktms.com

Twitter/X: GreenbrookTMS

Top Investors: Oxford Finance LLC, Madryn Asset Management, Alumni Capital LP, Greybrook Realty Partners, Masters Special Situations

Description:

Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.